Prelude Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,700
Closed -$82K 1988
2015
Q1
$82K Buy
+2,700
New +$70K 0.01% 1092
2014
Q2
Sell
-4,500
Closed -$58K 2121
2014
Q1
$58K Buy
+4,500
New +$64.5K 0.01% 1244

Other funds holding RGEN

Prelude Capital Management's RGEN Position: Q4 2024 in Review

Prelude Capital Management sold out of Repligen (RGEN) in Q4 2024, closing a stake of 1,790 shares — an estimated $266K sold.

Prelude Capital Management first reported a position in RGEN in Q3 2013 and held it in 22 quarters. The position peaked at $830K in Q3 2021. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Prelude Capital Management reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 1,790 Repligen shares in Q4 2024, an estimated $266K.
  • Prelude Capital Management first reported a position in Repligen in Q3 2013 and held it in 22 quarters.
  • Prelude Capital Management's Repligen position peaked at $830K in Q3 2021.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.